Our resource hub is home to a wealth of articles, stories and videos about managing and living with type 1 diabetes.
Place your order for our free information packs that support adults and children who have been recently diagnosed.
Our researchers are working on different ways to develop a cure for type 1 diabetes - from growing insulin-producing beta cells in labs to hacking the immune system.
Learn about the technologies that can deliver insulin automatically when needed. And discover the next generation of insulins that are currently being developed.
We have a wide range of fun and festive designs to choose from. Fund life changing research while spreading joy this Christmas!
This Christmas, your gift can bring us closer to a cure for type 1 diabetes – and every pound you give to our Christmas Appeal will be doubled.
The announcement is the biggest treatment breakthrough for type 1 diabetes since the discovery of insulin.
This event is designed for anyone living with type 1 diabetes who would like to learn more about managing their wellbeing across a variety of contexts.
We provide a wealth of information and free resources to help you support and empower your patients or students.
Take our free course for schools to learn more about supporting pupils with type 1 diabetes in educational settings.
Home > Knowledge & support > Resource hub > New knowledge about kidney disease risk for African-Caribbean people with type 1
A new study reveals people of an African–Caribbean ethnicity with type 1 diabetes have a higher risk of developing kidney complications. In fact, people from African-Caribbean backgrounds are nearly 60% more at risk of developing advanced kidney disease compared to people with type 1 from other ethnicities. Plus, the research shows this increased risk is not linked to other factors such as blood pressure or glucose levels.
It’s an important initial research study which starts to fill a gap in knowledge of how type 1 diabetes could progress differently across ethnic populations. This only coming to light now demonstrates that this area needs more research and funding.
With more research evidence, future treatments could effectively reduce type 1 diabetes complications based on patients’ individual ethnicity and biology. This could herald a form of personalised medicine.
Kidney disease has a devastating impact on people and their families. So, halting the onset and progression among people with type 1 is a key area of research focus.
Researchers at King’s College London conducted the study, which was published in the Diabetes Care Journal. They used NHS data from 5,000 people with type 1 over eight years across a diverse South London population.
The diversity of the NHS patient data is a particular strength of the study. This is because it allows for the risk factors across ethnicity and socio-economic class to be compared and controlled for.
Typically, US and European clinical research trials tend to have an over-representation of White trial participants. Additionally, most medical research occurs in Europe, North America, Asia and Australasia. This means the places where clinical research trials are conducted may miss important risk factors for African-Caribbean populations.
For all these reasons, this research study is an important step forward in knowledge. For more information, read our press release or the full research report. This study by King’s College London was supported by a research grant from Guy’s and St Thomas Hospital Charity.
Read our press release for more information about this research.
We can help you understand type 1 complications, the signs to look out for and what you can do to reduce your risk.
We fund world-class, international research to cure, treat and prevent type 1 diabetes and its complications.
Don’t miss out on the latest research, inspiring stories, tech news, upcoming events, and handy information on living well with type 1. Join us now and receive it all straight to your inbox.
It’s thanks to your dedication that we have funded great progress in type 1 cure, treatment and prevention research. Help us to continue our vital research.